𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma

✍ Scribed by Brian I. Rini; Mark Stein; Pat Shannon; Simantini Eddy; Allison Tyler; Joe J. Stephenson Jr; Lorie Catlett; Bo Huang; Diane Healey; Michael Gordon

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
273 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase 2 trial of talactoferrin in previo
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma
✍ Eric Jonasch; Walter M. Stadler; Ronald M. Bukowski; Teresa G. Hayes; Atul Varad πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Talactoferrin (TLF), a recombinant form of human lactoferrin (hLF), is an immunomodulatory iron‐binding glycoprotein first identified in breast milk. Its immunomodulatory functions include activation of natural killer (NK) and lymphokine‐activated killer cells and enhanc

A Phase I trial of fixed dose rate gemci
A Phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma
✍ Brian I. Rini; Vivian Weinberg; Eric J. Small πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Metastatic renal cell carcinoma (RCC) has modest response rates to chemotherapy with gemcitabine and 5‐fluorouracil (5‐FU). Fixed dose rate gemcitabine infusion leads to enhanced intracellular accumulation of drug and possible augmented clinical effect. To determine the t

Phase II trial of subcutaneously adminis
Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinoma
✍ Edward Wos; Thomas Olencki; Laurie Tuason; G. Thomas Budd; David Peereboom; Kate πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 465 KB πŸ‘ 2 views

## BACKGROUND. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine that is involved in the differentiation and proliferation of various hematopoietic precursors. It also has been reported to enhance the antitumor activity of various mature effector cells. Previous reports have